The Executive Protocol: Brain Fog and Fatigue Assessment
Sharp thinking on demand, but your brain keeps checking out. We test the markers behind cognitive fatigue. Treatment plans may include prescription peptides where your practitioner considers them clinically appropriate.
- Cognitive and Stress Marker Assessment
- Clinical Baseline and Ongoing Tracking
- Dedicated Practitioner Support
- No mark-up on medications or hidden service fees
Takes about 5 minutes. Includes an eligibility review and bulk-billed pathology where Medicare criteria are met.*
Most peptides sold online are unregulated

The TGA advises Australians to only obtain prescription medicines through licensed pharmacies under practitioner supervision. Unregulated peptides can pose serious health risks to consumers:
- ~30% mislabelled, under/over-dosed or contaminated
- No guaranteed sterility, with unverified supply chains
- Variable purity and composition the TGA warns could lead to serious harm
- Often contain unsafe concentrations of heavy metals like arsenic or lead
- Can contain harmful bacteria such as haemolytic Bacillus cereus
Sources: TGA safety alert; Sports Medicine (2026); Janvier et al., Talanta (2018); Janvier et al., Drug Testing & Analysis (2018).
Regeniq partners with TGA-licensed Australian compounding pharmacies, when they compound peptides one is sent to the patient and a second is sent to an independent lab for purity testing.

When injecting unregulated peptides, there is no continuity of care or any escalation pathways if you experience unwanted side effects:
- No one is responsible if something goes wrong
- Can be seized at the border, with fines or legal action
- Zero quality control
- Sold as "research use only" to limit liability
Each treatment pathway at Regeniq sits within the Australian regulatory framework, from AHPRA-registered practitioners to licensed compounding pharmacies. No shortcuts, no grey areas.

The regeniq difference

Clinical assessment & suitability overseen by AHPRA-registered Australian practitioners at every step

Medications compounded by TGA-licensed Australian pharmacies

Ongoing care, not a one-off script
Regeniq treatment is guided end to end by registered Australian practitioners. Where clinically appropriate, treatment is prescribed and compounded through TGA-licensed Australian pharmacies, with ongoing review built in.
What’s included
Every protocol is delivered by AHPRA-registered practitioners via secure telehealth consultations.
Cognitive and Stress Marker Assessment
We order targeted blood work focused on the markers that actually drive cognitive performance and stress response. Hormones, thyroid, glucose regulation, adrenal health. Your practitioner reviews all of it against your symptoms. Not one test in isolation. The full picture.
Clinical Baseline and Ongoing Tracking
Your initial blood work sets a clinical baseline. That matters because brain fog isn’t something you can eyeball over a quick consult. We track your markers over time through repeat pathology at structured intervals. If something shifts, we see it in the data and adjust accordingly.
Dedicated Practitioner Support
Your AHPRA-registered practitioner understands the demands of high-output professional life. They’re not going to tell you to ‘just relax’. You get ongoing consultations, coordinated care across relevant health areas, and communication with your GP where it makes sense.

Dealing with brain fog or chronic fatigue?
If stress, poor focus, or energy decline is affecting your performance, consider joining the waitlist to discuss whether this protocol is appropriate for you.
Frequently asked questions
What markers are assessed in the executive protocol?
How is this different from a standard GP health check?
Can I access this protocol if I work shift hours or travel frequently?
Treatment plans are personalised and prescribed only after medical consultation. Not all patients are suitable candidates. Risks and benefits will be discussed during your consultation. Medicare and private health insurance do not cover these services. Individual results may vary.
*Bulk-billing applies to pathology items that meet Medicare eligibility criteria and are clinically indicated by your practitioner. Some markers may not be Medicare-rebatable.